Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Edge Pharma, LLC
WARNING LETTER
•Edge Pharma, LLC•August 20, 2014

Edge Pharma, LLC – FDA Warning Letter, Aug 20, 2014

Record Details

On November 12, 2015, the FDA issued a Warning Letter to Edge Pharmacy Services, L.L.C., an outsourcing facility registered under section 503B of the FDCA. An inspection from July 22 to August 20, 2014, revealed serious deficiencies in sterile drug production, posing patient risks.

Violations include: - **Adulterated Drug Products:** Products were prepared under insanitary conditions (Section 501(a)(2)(A) FDCA) and failed to meet CGMP requirements (Section 501(a)(2)(B) FDCA). Specifically, the firm failed to demonstrate adequate protection of ISO 5 areas, lacked written procedures for preventing microbiological contamination and validating aseptic processes (21 CFR 211.113(b)), had an inadequate environmental monitoring system (21 CFR 211.42(c)(10)(iv)), and failed to test components for conformity (21 CFR 211.84(d)(2)). - **Unapproved New Drug Products:** The firm lacked FDA-approved applications for its drug products (Sections 301(d) and 505(a) FDCA). - **Misbranded Drug Products:** Labels lacked adequate directions for use for products not amenable to self-diagnosis (Section 502(f)(1) FDCA

Company
Edge Pharma, LLC
Inspection date
August 20, 2014
Product type
Drugs
Office
New England District Office
People
  • Joseph S. Matrisciano (Program Division Director)
  • Colin Benjamin
View Company Profile

ID · cde15fa9-55de-4c92-83de-905476745173

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 CFR 21021 CFR 21121 U.S.C. 331(d)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.

Other documents for Edge Pharma, LLC
  • 483 - 2021-11-30November 30, 2021
  • 483 - 2020-03-30March 30, 2020
  • 483 - 2018-03-08March 8, 2018
  • 483 - 2017-01-20January 20, 2017
  • 483 - 2014-08-20August 20, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Edge Pharma, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.